Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations
Open accessThe DOI matches its Crossref record; 208 of the 210 references it cites were found in a registry or an index; 90 of the 191 sources its claims cite were checked for support.
Abstract
Decellularized extracellular matrix (dECM) offers a three-dimensional, non-immunogenic scaffold, enriched with bioactive components, making it a suitable candidate for tissue regeneration. Although dECM-based scaffolds have been successfully implemented in preclinical and clinical settings within tissue engineering and regenerative medicine, the mechanisms of tissue remodeling and functional restoration are not fully understood. This review critically assesses the state-of-the-art in dECM scaffolds, including decellularization techniques for various tissues, quality control and cross-linking. It highlights the functional properties of dECM components and their latest applications in multiorgan tissue engineering and biomedicine. Additionally, the review addresses current challenges and limitations of decellularized scaffolds and offers perspectives on future directions in the field.
Overview
CoChat Summary
## TL;DR
This review surveys decellularized extracellular matrix (dECM) scaffolds for tissue engineering, covering sources, decellularization methods, characterization, postprocessing, and applications. It argues that dECM’s preserved 3D structure and bioactive cues make it promising for regeneration, organ engineering, and disease models, while key hurdles remain in decellularization standardization, recellularization, and vascularization.
## Key findings
- The authors report a Web of Science search for “Decellularized extracellular matrix” returned 5,458 scholarly works with 132,705 cumulative citations, showing rapid growth of the field.
- dECM scaffolds preserve native-like ECM cues while removing immunogenic cellular material; the review states they can support cell adhesion, migration, proliferation, and differentiation and reduce adverse immune reactions after implantation.
- In preclinical and clinical applications, dECM products and constructs are described for skin, musculoskeletal, cardiac, liver, kidney, lung, neural, bone, muscle, and organoid applications; examples named include AlloDerm, Oasis, GraftJacket, Allopatch HD, and CardioCel.
- A major bottleneck is vascularization: the paper notes rat liver scaffolds had 8 h post-transplant survival, extended to 24 h with anticoagulants; re-cellularized rat lung tissues exchanged gas for 45–120 min and survived up to 3 days post-transplant, and a lung-derived scaffold with islet cells formed a functional organ after 7 days of culture.
## Methods
- Narrative review article synthesizing prior studies on dECM sources, decellularization protocols, characterization techniques, postprocessing, and applications in tissue engineering and biomedicine.
- The review draws on published examples across tissues and organs and summarizes decellularization approaches including physical, chemical, enzymatic, and hybrid methods.
- It also reviews characterization and application literature using techniques such as histology, immunostaining, microscopy, mass spectrometry, PCR, Western blotting, SEM/TEM, OCT, AFM, and proteomics/matrisomics.
## Limitations
- The paper states there is no universally accepted standard for decellularization because outcomes depend on tissue heterogeneity such as species, age, anatomical site, and size.
- It explicitly notes unresolved challenges in incomplete cellular removal, preservation of ECM bioactivity, structural integrity, vascularization, microbial contamination, complexity, and scalability.
- Evident from the text: this is a review, so it does not present a single primary experimental dataset or a new comparative trial; instead it compiles prior studies and examples.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![FIGURE 3 Structural and morphological analysis of the dECM scaffolds. (A) HE staining of decellularized rat liver scaffolds. Reproduced with permission.[ 92 ] Copyright 2021, Elsevier. (B) Immunofluorescent staining of decellularized mouse liver scaffolds (collagen IV). Reproduced under Attribution‐Non Commercial‐No Derivs 4.0 International License (CC BY‐NC‐ND 4.0 DEED).[ 113 ] Copyright 2023, The Authors. (C) Immunohistochemical staining of decellularized rat liver scaffolds. Reproduced with permission.[ 92 ] Copyright 2021, Elsevier. (D) SEM imaging of decellularized rat liver scaffolds. Reproduced with permission.[ 92 ] Copyright 2021, Elsevier. (E) AFM imaging of mouse lung ECM. Reproduced under CC BY‐NC‐ND 3.0 License.[ 110 ] Copyright 2010, The Author(s), published by Elsevier. (F) TEM imaging of decellularized rat liver scaffolds. Reproduced with permission.[ 92 ] Copyright 2021, Elsevier. (G) Swept‐source OCT (Optical Coherence Tomography) imaging of 3D bioprinted decellularized collagen grafts implanted into the cornea. Reproduced under the terms of the CC‐BY 4.0 license.[ 114 ] Copyright 2019, The Authors. (H) Cross‐sectional UHR‐SD‐OCT image of membranous septum imaged from left ventricular aspect of a porcine heart. Reproduced with permission.[ 115 ] Copyright 2022, Optica Publishing Group. (I) Wide‐angle synchrotron X‐ray scattering pattern from the central cornea. Reproduced with permission.[ 111 ] Copyright 2004, Elsevier. (J) Representative 3D reconstructed micro‐CT images 8 weeks after the implantation of SIS‐based scaffolds. The new bone formation ratio. Reproduced under the terms of the Creative Commons Attribution License (CC BY).[ 116 ] Copyright 2022, The Authors. (K) Confocal Raman microscopy analysis of ECM derived from decellularized bovine endometrium. Reproduced under the terms of the Creative Commons Attribution License.[ 107 ] Copyright 2021, Simsa et al. (L) Birefringence polarization imaging of healthy rat hearts. Reproduced under the terms of the Creative Commons Attribution License (CC BY).[ 108 ] Copyright 2021, The Author(s). (M) Second harmonic generation imaging of alcoholic cirrhosis in patients. Reproduced under the terms of the Creative Commons Attribution License (CC BY).[ 109 ] Copyright 2023, The Authors.](https://figures.cochat.ai/paper-figures/2450b11e948742b5968132270133a8eb/bioactive-scaffolds-for-tissue-engineering-a-review-of-decellularized-figure-3.jpg)


![FIGURE 6 Applications of decellularized scaffolds in tissue engineering. (A) The decellularized heart scaffold was recellulated to form (a,b) a working perfusion bioartificial heart‐like structure, which showed (c) electrical response and contractile function. Reproduced with permission.[ 148 ] Copyright 2008, Springer Nature. (B) After recellularization, the decellularized liver matrix produces transplantable liver grafts to support liver‐specific functions, including albumin secretion and urea synthesis. Reproduced with permission.[ 189 ] Copyright 2018, American Chemical Society. (a) Photograph of circulating perfusion system and the TE liver after recellularization with ≈30 million hepatocytes. (b) Analysis of albumin secretion and urea synthesis of HepG2 cells under 2D, TE, and TEF liver cultures. (C) The decellularized lung scaffold performs gas exchange function after implantation by epithelial cells and endothelial cells. Reproduced with permission.[ 175 ] Copyright 2010, Springer Nature. (a) Fluorescence micrographs of reendothelialized lung constructs (scale bars, 200 µm). (b) H&E‐stained low‐ (×10) and high‐power views (×40, insets) of A549‐seeded lung constructs (scale bars, 200 µm). (c) Blood gas analyses of pulmonary venous effluent, the dynamic pressure/volume relationship during five respiratory cycles and vital capacity of native lung, HUVEC‐ and A549‐seeded lung (H‐A549), and HUVEC‐ and fetal lung cell–seeded lung (H‐FLC). (D) By the recellularization of epithelial cells and endothelial cells, the decellularized scaffolds of rat kidney were transformed into bioengineered kidney grafts with the function of urine production after orthotopic transplantation. Reproduced with permission.[ 171 ] Copyright 2013, Springer Nature. (a) Schematic of cell seeding and whole organ culture of decellularized rat kidneys. (b) Average urine flow rate (mL min−1), average creatinine clearance and vascular resistance for decellularized, cadaveric, and regenerated kidneys perfused at 80 mmHg and regenerated kidneys perfused at 120 mmHg (regenerated*). (E) The bioscaffolds derived from the central nervous system have cytocompatibility after co‐culture with PC12 cell lines in vitro, and stimulate proliferation, migration and differentiation, thus contributing to functional recovery after CNS injury. Reproduced with permission.[ 177 ] Copyright 2012, Elsevier. (a) Cytocompatibility of CNS ECM scaffolds. Magnification is 400×. (b) Mitogenic effects and chemotactic effects of CNS ECM scaffolds. (F) The Gel‐dECM‐Qcs (GDQ) composite scaffold formed by 3D printing technology combining decellularized pig skin scaffold, temperature sensitive gelatin (Gel) and quaternized chitosan has good mechanical properties, biocompatibility and antibacterial ability. Reproduced with permission.[ 182 ] Copyright 2023, Elsevier. (a) Live/dead staining of L929 cells in different pure/composite scaffolds including Gel, Gel‐dECM and Gel‐dECM‐Qcs. Scale bar = 500 µm. (b) Representative images of colony count of the scaffolds against Escherichia coli and Staphylococcus aureus. Organ schematic images from BioRender.com.](https://figures.cochat.ai/paper-figures/9df85e5e62524c7c8ff58701150d060d/bioactive-scaffolds-for-tissue-engineering-a-review-of-decellularized-figure-6.jpg)
![FIGURE 7 Applications of decellularized scaffolds in organoid culture. (A) Representative images of lung organoids encapsulated in A‐dECM and D‐dECM hydrogels and stained for calcein‐AM (green) and PI (red) on day 10. Reproduced under the terms of the CC‐BY 4.0 License.[ 197 ] Copyright 2023, The Authors. (B) Human pediatric gastric enteroids in ECM gel (a), and forming mouse intestinal organoids per field of view at day 4 of culture in ECM gel and Matrigel over two passages (b). Reproduced under a Creative Commons Attribution 4.0 International License.[ 195 ] Copyright 2019, The Authors. (C) Brain organoids on day 10 in Matrigel (top pictures) or B‐ECM hydrogel (bottom pictures). On day 40, no significant difference is apparent. White arrows at day 10 point to ventricular‐like zones located in the formed neuronal buds. White arrowhead at day 40 indicates residual B‐ECM hydrogel. Reproduced under the terms of the Creative Commons Attribution License.[ 198 ] Copyright 2021, The Authors. (D) Tissue sections of brain organoids cultured in Matrigel (left panels) or B‐ECM hydrogel (right panels) for 40 days were immunostained for neuronal progenitor markers (SOX2, Nestin, PAX6) and mature neuronal markers (DCX, β‐Tubulin III, MAP2). DAPI was used as nuclear counterstaining. White arrowheads indicate ventricular like zones that were chosen for magnification. Reproduced under the terms of the Creative Commons Attribution License.[ 198 ] Copyright 2021,The Authors. (E) Bright‐field images of mouse endometrial organoids in Matrigel and endometrial hydrogels (P1–P3, a–d). Reproduced under Creative Commons Attribution‐Non Commercial‐No Derivatives License 4.0 (CC BY‐NC‐ND).[ 107 ] Copyright 2022, the Authors. (F) The organoid forming efficiency of mouse endometrial organoids in Matrigel and P1–P3 hydrogel (a); Percentages of organoid nos. representing round, tubular, and glandular‐shaped organoids in Matrigel versus P1 (b). Reproduced under Creative Commons Attribution‐Non Commercial‐No Derivatives License 4.0 (CC BY‐NC‐ND).[ 107 ] Copyright 2022, the Authors. (G) H&E and immunostaining for Foxa2, Ck8, and Ki67 of organoids cultured in Matrigel and P1 hydrogel. Reproduced under Creative Commons Attribution‐Non Commercial‐No Derivatives License 4.0 (CC BY‐NC‐ND).[ 107 ] Copyright 2022, the Authors.](https://figures.cochat.ai/paper-figures/7020853a0278466895dee2af9da17333/bioactive-scaffolds-for-tissue-engineering-a-review-of-decellularized-figure-7.jpg)
Verification
Claims the paper makes
75 Valid · 35 Not valid · 76 Not checked · 73 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Vermeulen et al. developed hydrogels from decellularized porcine immature testicular tissue (ITT) that successfully generated testicular organoids (TOs).”
§ Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations > CONTEMPORARY UTILIZATION OF DECELLULARIZED SCAFFOLDS IN TISSUE ENGINEERING > Decellularized scaffolds provide a new platform for the establishment of in vitro models
What the sources say
- Disputedcites [200] M. Vermeulen, F. Del Vento, F. De Michele, J. Poels, C. Wyns, Int. J. Mol. Sci. 2018, 19, 227. 29329231 PMC5796176 sourceExperimental — accuracy not yet measured
The Abstract reports a decellularized pig immature testicular tissue scaffold that supported human Sertoli cells, not a hydrogel that generated organoids. The Discussion explicitly proposes developing a hydrogel as future work and describes organoid formation as an application reported elsewhere. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The ECM's functional characteristics and structural components, such as collagen and proteoglycans, play a critical role in maintaining tissue homeostasis and promoting angiogenesis.”
§ Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations > INTRODUCTION
What the sources say
- Not checked — no full text of the sourcecites [4] A. D. Theocharis, S. S. Skandalis, C. Gialeli, N. K. Karamanos, Adv. Drug Delivery Rev. 2016, 97, 4. 26562801 source
- Supportedcites [5] J. Huang, L. Zhang, D. Wan, L. Zhou, S. Zheng, S. Lin, Y. Qiao, Signal Transduction Targeted Ther. 2021, 6, 153. PMC8062524 33888679 source
The Fibroblasts section says the balance of ECM components is critical to tissue homeostasis. The ECM and growth factors section identifies collagen and a proteoglycan in ECM signaling and describes an ECM-related process that promotes angiogenesis; the Elastin and laminin section also links a basement-membrane component to vascularization. The claim is a broad paraphrase of these roles. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Numerous decellularization protocols have been developed, encompassing an array of physical, chemical, and enzymatic treatments, often in combination.”
§ Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations > PREPARATION METHODS OF DECM SCAFFOLDS
What the sources say
- Not checked — no full text of the sourcecites [26] J. Willemse, M. M. A. Verstegen, A. Vermeulen, I. J. Schurink, H. P. Roest, L. J. W. van der Laan, J. de Jonge, Mater. Sci. Eng., C 2020, 108, 110200. 31923991 source
- Not checked — no full text of the sourcecites [27] N. Nieto‐Nicolau, P. López‐Chicón, O. Fariñas, S. Bolívar, E. Udina, X. Navarro, R. P. Casaroli‐Marano, A. Vilarrodona, Cell Tissue Res. 2021, 384, 167. 33471198 source
- Supportedcites [28] L.‐C. Wu, Y.‐J. Kuo, F.‐W. Sun, C.‐H. Chen, C.‐J. Chiang, P.‐W. Weng, Y.‐H. Tsuang, Y.‐Y. Huang, Cell Tissue Banking 2017, 18, 383. 28342099 PMC5587617 source
The Discussion states that numerous studies have investigated decellularization protocols using chemical, physical, and enzymatic methods. The Materials and methods section describes a protocol combining freeze–thaw, detergent treatment, and DNase/RNase treatment. Page numbers are not provided in our copy. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Initially used in decellularization for its efficacy in disrupting tissue ultrastructure and enhancing the penetration of other agents, trypsin may nevertheless impact ECM mechanics.”
§ Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations > PREPARATION METHODS OF DECM SCAFFOLDS > Progress in decellularized scaffold preparation using enzymatic treatments
What the sources say
- Supportedcites [43] S. Rahman, M. Griffin, A. Naik, M. Szarko, P. E. M. Butler, Sci. Rep. 2018, 8, 3097. 29449572 PMC5814427 source
The Methods (Decellularization process; page unavailable) say trypsin exposure was limited to avoid damaging the ECM, supporting the cautious claim that it may affect the matrix. The Results (Mechanical properties; page unavailable) found no significant change in Young’s modulus for the tested trypsin protocol, so the paper does not report mechanical damage under those conditions. (LLM, conf=0.84)
- Partly supportedcites [44] E. Rieder, M.‐T. Kasimir, G. Silberhumer, G. Seebacher, E. Wolner, P. Simon, G. Weigel, J. Thorac. Cardiovasc. Surg. 2004, 127, 399. 14762347 sourceExperimental — accuracy not yet measured
The Discussion of Rieder et al. (2004) does carry a trypsin-damages-the-matrix point, but it is relayed from another work: 'Bader and colleagues described that a longer incubation with trypsin might be more effective in cell removal but causes a disruption of the matrix bundles.' That is a structural/morphological effect on matrix bundles, not a measured effect on ECM mechanics, and this paper reports no mechanical data of its own — the same Discussion states that 'further studies concerning mechanical testing are currently under investigation in our laboratory,' while its own trypsin findings concern only incomplete cell removal and successful endothelial attachment (Abstract; ACD Results). So the source supports the general idea that trypsin can compromise the matrix, but the mechanics framing is not this study's own finding and the underlying observation is credited to Bader et al. (LLM, conf=0.72)
- Not checked — no full text of the sourcecites [45] J. Paulo Zambon, A. Atala, J. J. Yoo, Methods 2020, 171, 3. 31606388 source
- Not checked — no full text of the sourcecites [46] B. Yang, Y. Zhang, L. Zhou, Z. Sun, J. Zheng, Y. Chen, Y. Dai, Tissue Eng., Part C 2010, 16, 1201. 20170425 source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“To circumvent animal‐borne diseases and potential residual contamination and immunogenicity of xenogeneic dECM from animals, clinicians prefer human tissue for applications.”
§ Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations > THE SOURCE OF DECM SCAFFOLDS > Human or animal organs/tissues source
What the sources say
- Not checked yetcites [15] J. Duisit, H. Amiel, T. Wüthrich, A. Taddeo, A. Dedriche, V. Destoop, T. Pardoen, C. Bouzin, V. Joris, D. Magee, E. Vögelin, D. Harriman, C. Dessy, G. Orlando, C. Behets, R. Rieben, P. Gianello, B. Lengelé, Acta Biomater. 2018, 73, 339. 29654989 source
Checked before — its earlier verdict is held back until a new check runs.
- Supportedcites [16] A. Porzionato, E. Stocco, S. Barbon, F. Grandi, V. Macchi, R. De Caro, Int. J. Mol. Sci. 2018, 19, 4117. 30567407 PMC6321114 source
The Introduction says xenogeneic tissues from animals may retain immunogenicity or be contaminated with biological agents, and describes human allogeneic tissues as the ideal material for ECM intended for recellularization and implantation. This supports the stated rationale for preferring human tissue, though the paper does not report a survey of clinicians' preferences. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not checked yet
90 more claims · 32 with their cited sources checked
Create a free account to see all 259 claims and to verify the 16 references still open.
- Probably not a substantial claim. 82
- It may state two separate claims as one. 111
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Matrix extracts from decellularized organs contain far more of the matrix components in vivo and preserve intact the many matrix components with their normal relationships with each other, providing effects able to reestablish histological and functional aspects of the organ [[13], [14], [15]].”
From Decellularized liver scaffolds for constructing drug-metabolically functional ex vivo human liver models (2025) · cites this paper as [13]
Experimental — accuracy not yet measured
Citations
Cites
Two-photon laser scanning fluorescence microscopy
Denk, W., Strickler, J. H., & Webb, W. W. (1990) · Science · doi:10.1126/science.2321027 · Cited by 9,488
An overview of tissue and whole organ decellularization processes
Crapo, P. M., Gilbert, T. W., & Badylak, S. F. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.057 · Cited by 3,591
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart
Ott, H. C., Matthiesen, T. S., Goh, S.-K., Black, L. D., Kren, S. M., Netoff, T. I., & Taylor, D. A. (2008) · Nature Medicine · doi:10.1038/nm1684 · Cited by 2,650
Extracellular matrix structure
Theocharis, A. D., Skandalis, S. S., Gialeli, C., & Karamanos, N. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.001 · Cited by 2,598
Decellularization of tissues and organs
Gilbert, T. W., Sellaro, T. L., & Badylak, S. F. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.02.014 · Cited by 2,222
Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink
Pati, F., Jang, J., Ha, D.-H., Won Kim, S., Rhie, J.-W., Shim, J.-H., Kim, D.-H., & Cho, D.-W. (2014) · Nature Communications · doi:10.1038/ncomms4935 · Cited by 1,904
Heparan sulphate proteoglycans fine-tune mammalian physiology
Bishop, J. R., Schuksz, M., & Esko, J. D. (2007) · Nature · doi:10.1038/nature05817 · Cited by 1,631
Uygun, B. E., Soto-Gutierrez, A., Yagi, H., Izamis, M.-L., Guzzardi, M. A., Shulman, C., Milwid, J., Kobayashi, N., Tilles, A., Berthiaume, F., et al. (2010) · Nature Medicine · doi:10.1038/nm.2170 · Cited by 1,370
Naba, A., Clauser, K. R., Hoersch, S., Liu, H., Carr, S. A., & Hynes, R. O. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014647 · Cited by 1,354
Overview of the Matrisome--An Inventory of Extracellular Matrix Constituents and Functions
Hynes, R. O., & Naba, A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004903 · Cited by 1,349
Research works printed but not linked: 4
- Gilbert T. W., 2006, Biomaterials, 27, 3675
- Li N., 2011, Mol. Vis., 17, 1909
- Pulver null, 2014, CryoLetters, 35, 400
- Russell H. K., 1972, Arch. Pathol., 94, 187
Cited by
Items 101–133 of 133
Liu, N., Zhao, J., Jing, H., Chen, L., Liu, B., Zhang, W., & Tang, S. (2026) · Journal of Polymer Science · doi:10.1002/pola.70176
Wei, C., Sun, H., Long, J., Liu, X., Li, Q., & Cao, B. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117308
Biomaterial-based microenvironment remodeling for functional regeneration of scarred uterus tissue
Yang, W., Xu, Y., Xie, W., & Pan, X. (2026) · Journal of Materials Chemistry B · doi:10.1039/d6tb01146b
Kwon, J. W., Jeon, J., Yang, S. W., Chung, Y., Park, J. H., Joung, Y. K., Yang, H. S., & Park, K. (2026) · Biomaterials Research · doi:10.34133/bmr.0410
“Due to its ability to recapitulate the native microenvironment, ECM has emerged as an attractive biomaterial in tissue engineering, offering a cell-free platform that promotes tissue regeneration [ 11 ].”
Xu, C., Zhang, Z., Jin, Q., Cao, G., Liu, Z., Wan, J., Ji, P., Xu, L., Ju, J., Le, Y., et al. (2025) · Materials Today Communications · doi:10.1016/j.mtcomm.2025.113049 · Cited by 1
Self-citationInjectable Hydrogels for Treating Osteonecrosis of the Femoral Head
Askari, M., Rajabi, A., & Dortaj, H. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00486-x
Biomaterial‐Focused Strategies Targeting Dendritic Cells for Autoimmune Disease Treatment
Kumar, A. V. S., & Babensee, J. E. (2026) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.70107
Peh, W. Y., Abdullah, D., Ng, S. L., Soo, E., Apandi, N. I. M., & Ghani, N. A. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198599
Chen, G., Yang, A., Yin, S., Liu, Q., Wu, H., & Wang, L. (2026) · Biomedical Engineering Letters · doi:10.1007/s13534-026-00569-w
Ling, S., Liu, M. D., Meng, C., Huo, K., Wang, Y., Zhang, Y., Wei, Y., Zhou, L., Du, Y., & Cui, W. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.04.038
“Decellularized extracellular matrix (dECM) holds great potential due to its preserved bioactive components and native ECM signals [34 – 38].”
Self-citationWhat Is a Scaffold? Scaffolds in Materials Science and Applications
Sáez, J. S. D. R., Díaz, Á. G. D. L. C., Moraleda, L., Mora, M. V., & Sánchez, A. L. (2026) · Series in bioengineering · doi:10.1007/978-981-95-7557-2_3
Suresh, N., Lekhavadhani, S., & Selvamurugan, N. (2026) · World Journal of Orthopedics · doi:10.5312/wjo.v17.i1.113228
“Central to this paradigm is the development of scaffolds that recapitulate the structural, mechanical, and biochemical characteristics of the native extracellular matrix (ECM), thereby facilitating cell adhesion, migration, proliferation, and osteogenic differentiation[10].”
Regenerative Nano-scaffolds for Tissue Engineering: From Bench to Clinical Translation
Kim, W., Park, S., Beom, S. W., Choi, S., Yang, H.-W., Kim, D., Lee, S., Sharma, H., Park, C., Lee, W.-P., et al. (2026) · Biomaterials Research · doi:10.34133/bmr.0414
“Although membrane-based scaffolds are widely used, most of them serve only passive roles such as wound coverage and barrier protection, and they lack intrinsic therapeutic functionality, including the ability to actively promote tissue regeneration [ 2 , 3 ].”
Chondrogenic niche hydrogel microspheres facilitate cartilage regeneration in osteoarthritis
Chen, J., Xiao, P., Wang, X., Tan, J., Du, C., Chen, Z. H., Tang, B., Zhang, P., Liu, J., Sun, Y., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.07.024 · Cited by 2
“Tissue regeneration is a core objective in modern biomedicine [1,2].”
Self-citationHamner, G., & Brown, J. L. (2026) · Regenerative Medicine · doi:10.1080/17460751.2026.2672913
“Once the decellularization process is complete, either the whole matrix can be transplanted or lyophilized into powder to create hydrogels and bio-inks for more intricate assembly [29,103].”
Li, R., Lin, L., Jiang, S., & Lu, J. (2026) · Process Biochemistry · doi:10.1016/j.procbio.2026.08.018
Zhu, M., Zhang, H., Liang, L., Wu, S., & Chen, J. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1787909
Wu, Y., Lu, W., Salas-Hernandez, J. L., Wang, R., Zhao, Z., Zheng, W., Li, Y., & Liao, J. (2026) · Journal of Materials Chemistry B · doi:10.1039/d6tb00934d · Cited by 1
Growth Factor-Free Engineered Biphasic Scaffold for Enhanced Bone Regeneration
Wijekoon, S., Wang, W., Abdulmalik, S., Zennifer, A., Srinivasan, S. S., Yu, X., & Kumbar, S. G. (2025) · Annals of Biomedical Engineering · doi:10.1007/s10439-025-03857-1 · Cited by 1
“The radiographic and micro-CT results demonstrate that dECM-containing scaffolds (G1 and G4) provide robust osteogenic support comparable to autograft (G6), the clinical gold standard [49].”
A Dynamic Modeling Framework for Real-Time Monitoring of Porcine Lung Tissue Decellularization
Wang, Z., Bedsaul, A., Hincher, C. G., Jimenez-Socha, M., White, S. E., Sze, D., Ducoste, J. J., Mora‐Navarro, C., & Freytes, D. O. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6c00414
Adult stem cells in regenerative medicine of respiratory system
Yaghoubi, A., Nazarnezhad, S., Asgharzadeh, F., Saeinasab, M., & Sefat, F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34152-6.00008-1
Adipose-derived products: from volumetric restoration to microenvironment remodeling
Lu, L., Lu, C., & Dong, Z. (2026) · Plastic and Aesthetic Research · doi:10.20517/2347-9264.2026.45
Srinivasan, S. S., Wijekoon, S., Zennifer, A., Abdulmalik, S., & Kumbar, S. G. (2025) · International Journal of High Speed Electronics and Systems · doi:10.1142/s0129156426400124 · Cited by 1
Song, G., Cong, W., Lu, H., Wang, J., Wang, Y., Zhao, Y., Wang, S., Zhu, S., Midgley, A. C., Li, W., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.05.002 · Cited by 1
Self-citationSedar, J. A. M. D., Utomo, D. N., Widiyanti, P., & Suroto, H. (2026) · The International Journal of Artificial Organs · doi:10.1177/03913988261474356
Engineering organoids toward implantable living therapeutics
Shi, Z., Yang, Q., You, X., Wang, H., Wang, H., & Zhao, G. (2026) · hLife · doi:10.1016/j.hlife.2026.06.002
Geng, J., Li, H., Fan, R., Wang, C., Gong, H., & Guo, G. F. (2026) · Polymer Testing · doi:10.1016/j.polymertesting.2026.109341
Towards a bioengineered airway: advances in tracheal tissue engineering and biofabrication
Prasad, P. R., Sahni, P. K., Mondal, D., Vasanthan, K. S., Varadharajan, S., Kumar, A., Shridhar, N. B., Kumar, N. A. N., Bisht, B., Paul, K., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1713743 · Cited by 4
“…rejection, promote effective tissue integration and neo-vascularization, facilitate regeneration of functional mucociliary epithelium, ensure mechanical stability and long-term airway patency, and ultimately achieve successful clinical reconstruction (Greaney et al., 2023; Liu et al., 2024).”
Modulating Calcium Homeostasis via a Biomimetic Scaffold to Rescue Diabetic Ischemic Wounds
Zheng, X. J., Li, M., Jiang, J., Wang, Y., Jia, Y., Sun, W. T., Yao, Y., Gao, P., Zhang, L., Guo, Q., et al. (2026) · Advanced Science · doi:10.1002/advs.76758
“This ECM breakdown, specifically at the nanoscale, deprives cells of the topographical signals needed for directed migration [ 3, 4 ].”
Self-citationda Silva-Júnior, L. N., Miglino, M. A., Horvath-Pereira, B. D. O., Fireman, J. V. B. T., da Siqueira, G. M., Pereira, M. L. D. R. F., Bezerra, L. D. S., de Oliveira, L. V. F., Morais, S. D. S., Bellini, M. Z., et al. (2026) · Bioengineering · doi:10.3390/bioengineering13050484
“…aspect to be observed is the physiological function of gas exchange, which must remain intact after decellularization with scaffolds maintaining properties such as strength, elasticity, cellular remodeling, geometry, cell adhesion, and proliferation, as well as nutrient transfer [39,41–44].”
Ghosh, D., Das, S., & Sarkar, K. (2026) · Journal of Macromolecular Science Part A · doi:10.1080/10601325.2026.2680456
Stromal cell–mediated tuning of the extracellular matrix for immune tissue engineering
Hammel, J. H. (2026) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2026.100677
pADM patch augmentation for rotator cuff repair: In vivo safety and efficacy in a canine model
Li, J., kong, Q., Xu, Q., & Wang, K. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1912857
Metadata
- Authors
- Liu, J., Song, Q., Yin, W., Li, C., An, N., Le, Y., Wang, Q., Feng, Y., Hu, Y., & Wang, Y.
- Affiliations
- Beijing Tsinghua Chang Gung Hospital (CN)
- Beijing University of Technology (CN)
- Zhejiang Sci-Tech University (CN)
- Jilin University (CN)
- Corresponding author
- Liu, Juan
- Wang, Yunfang
- Venue
- Exploration
- Publisher
- Wiley
- Published
- 2024-04-11
- Volume
- 5
- Issue
- 1
- Pages
- 20230078-20230078
- ISSN
- 2766-2098 (ISSN-L)
- 2766-8509
- PMC
- PMC11875452
- OpenAlex
- W4394758519
- Cited by
- 140
- References
- 210
- Citations by year
- 2026: 73 · 2025: 52 · 2024: 15
- FWCI
- 15.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Exploration (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (32371477, 92168207, 82090051)
- National Key Research and Development Program of China (2022YFA1103400, 2022YFC2406704)
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Keywords
- decellularized extracellular matrix, tissue engineering scaffolds, tissue regeneration, tissue remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.